Last reviewed · How we verify
Vit C
At a glance
| Generic name | Vit C |
|---|---|
| Also known as | Ascorbic acid |
| Sponsor | Institute of Liver and Biliary Sciences, India |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Toddler Biomarker of Nutrition Study (NA)
- The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists (PHASE1)
- Regenerative Potentials of Mature Mandibular Molars With Symptomatic Irreversible Pulpitis Enhanced With Different Scaffolds (NA)
- Urine and Ultrasound Screening for Kidney Disease in Children (NA)
- The Body's Affect on Vitamin C (PHASE1)
- A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC (PHASE2)
- Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial (NA)
- Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vit C CI brief — competitive landscape report
- Vit C updates RSS · CI watch RSS
- Institute of Liver and Biliary Sciences, India portfolio CI